期刊文献+

HPLC法测定洛伐他汀分散片的含量及含量均匀度 被引量:2

Determination of Content and Content Uniformity of Lovastatin Dispersible Tablet by HPLC
原文传递
导出
摘要 目的:建立测定洛伐他汀分散片含量及含量均匀度的方法,为其仿制生产和贮存期质量控制提供参考。方法:采用高效液相色谱法。色谱柱为Waters MS C18,流动相为乙腈-0.01%磷酸(55∶45,V/V),检测波长为238 nm,柱温为30℃,流速为1.0 ml/min,进样量为20μl。结果:洛伐他汀检测质量浓度线性范围为20.32-609.60μg/ml(r=0.999 9);精密度、稳定性、重复性试验的RSD〈1%;回收率为99.60%-101.68%,RSD=0.8%(n=9)。结论:该方法的重复性好、准确度高,适于洛伐他汀分散片的质量控制。 OBJECTIVE:To establish a method for the determination of content and content uniformity in Lovastatin dispersible tablet,to provide reference for the quality control of its peneric production and storage period. METHODS:HPLC method was adopted on the column of Waters MS C_(18) with mobile phase of acetonitrile-0.01% phosphoric acid(55 ∶ 45,V/V),detection wavelength was 238 nm,column temperature was 30 ℃,flow rate was 1.0 ml/min,and the volume injection was 20 μl. RESULTS:The linear range of lovastatin was 20.32-609.60 μg/ml(r=0.999 9);RSDs of precision,stability and reproducibility tests were lower than 1%;recovery was 99.60%-101.68%(RSD=0.8%,n=9). CONCLUSIONS:The method is reproducible with high accuracy,and suitable for the quality control of Lovastatin dispersible tablet.
作者 裘一婧 孙婷
出处 《中国药房》 CAS 北大核心 2016年第9期1285-1287,共3页 China Pharmacy
关键词 高效液相色谱法 洛伐他汀分散片 含量 含量均匀度 HPLC Lovastatin dispersible tablets Content Content uniformity
  • 相关文献

参考文献6

二级参考文献33

  • 1Alberts AW,Chen J,Kuron G,Hunt V,Hoffman C,Rothrock J,Lopez M,Joshua H,Harris E,Patehett A,Hensens O,Hirshfied J,Hoogsteen K,Liesch J,Springer J.Proceedings of the National Academy of Science USA,1980,77:3957 ~ 3961.
  • 2Jemal M,Ouyang Z,Powell M L.Journal of Pharmaceutical and Biomedical Analysis,2000,23:323 ~ 340.
  • 3Li Y G,Zhang F,Wang Z T,Hu Z B.Journal of Pharmaceutical and Biomedical Analysis,2004,35:1101~1112.
  • 4Wang H,Wu Y H,Zhao Z X.Journal of Mass Spectrometry,2001,36:58~70.
  • 5Rindone J P,Achacoso R,Bledsoe R.The American Journal of Cardiology,1995,76(4):312 ~313.
  • 6Fong R L,Ward H J.The American Journal of Medicine,1997,102(4):387 ~391.
  • 7刘小宝.高效液相色谱法测定血脂康软胶囊中洛伐他汀的含量[J].江西中医药,2007,38(7):76-76. 被引量:4
  • 8Michel MC, Li Y, Heusch G. Mitogen-activated protein ki nases in the heart [J]. Naunyn Schmiedebergs Arch Pharma col, 2001, 363(3):245-266.
  • 9Grossini E, Molinari C, Caimmi PP, et al. Levosimendan in- duces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitoehondrial K (ATP) channel [J]. Br J Pharmacol, 2009, 156(2): 250- 261.
  • 10Kocsis GF, Pipis J, Fekete V, et al. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts [J]. Am J Physiol Heart Circ Physiol, 2008, 294(5):2406-2409.

共引文献20

同被引文献19

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部